North Dakota HB 1139: Relating to duration limits for opioid therapy and benzodiazepine; and to provide for application.

Status: Filed with Secretary Of State 04/01 (as of 2021-04-05)

State: North Dakota · Session: 67 · Bill: HB 1139

Sponsors: Keiser, Klein

View North Dakota HB 1139 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.